Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACROBAT Edge: Paltusotine in Acromegaly
NCT03789656Phase 2Completed
- Sponsor
- Crinetics Pharmaceuticals
- Start
- Mar 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of paltusotine in acromegaly, sponsored by Crinetics Pharmaceuticals. Started Mar 2019; status: completed.
02
Drugs
paltusotine
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT03789656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03789656.